公司簡介
珍誠生物技術有限公司於2017年成立;其主意專注在開發和促進香港，內地以至海外生物技術相關的產業及商業發展。珍誠成立至今的研發及營運拓展迅速，業績優良。
研發背景
公司用於製造EGF和bFGF的核心技術，
經過超過30年的研發，黃教授的團隊得到 專有的生物系統及提純技術，可被應用在
科研團隊
黃允強教授 首席技術總監
黃允強教授於1986年從英屬哥倫比亞大學(UBC)取得微生物學博士學位，現委任於香港科技大學生命科學部榮譽退休及兼職教授。黃教授除了是一位微生物學家，他還擅長分子生物學，免疫化學和發酵技術。此外，他在生物科技的研發和應用上也擁有超過30年的經驗。
透過先進的基因重組技術與精簡的提純程序，黃教授團隊成功地將真實和優質EGF和bFGF的製造成本大大降低; 從而方便用家將這兩個因子皮膚生長應用到美容護膚和醫學領域上。團隊在皮膚因子的商業開發在拓展生物技術於護膚美容的應用和產業上作出了重大貢獻。
權威認證
Wong, W.K.R. (2020)
Wong, W.K.R., Ng, K.L. (2020) Means and method for enhancing growth of fish. Japanese patent No.: 6707441; Granted on May 22, 2020.
Wong, W.K.R. (2020) Means and method for expression of authentic human epidermal growth factor and/or basic fibroblast growth factor in cytoplasm and/or Culture Medium of Escherichia coli. Chinese Patent No. CN 105143451 B; Granted on 14 February 2020.
Wong, W.K.R. (2019)
Wong, W.K.R.,Hu, X.H., Ng, K.L. and Lam, C.C. (2019) Methods and means for expression of authentic and bioactive basic fibroblast growth factor in Bacillus subtilis. Hong Kong Short-term Patent No. HK1255118; Granted on 2 Aug 2019.
Wong, W.K.R., Kwong, W. Y. (2019) Improved means and method for hyper-production of authentic human basic fibroblast growth factor in Escherichia coli. US Patent No. 10,273,520; Granted on April 30, 2019
Wong, W.K.R. (2018)
Wong, W.K.R., Hu, X.H., Ng, K.L. and Lam, C.C. (2018) Methods and means for expression of authentic and bioactive basic fibroblast growth factor in Bacillus subtilis. USA, China and Japan (under application).
Wong, W.K.R. (2018) Means and method for expression of authentic human epidermal growth factor and/or basic fibroblast growth factor in cytoplasm and/or culture medium of Escherichia coli Japan Patent No.6404901. Granted on 21 Sept 2018.
Wong, W.K.R. (2017)
Wong, W.K.R., Kwong, W. Y. (2017) Improved means and method for hyper-production of authentic human basic fibroblast growth factor in Escherichia coli. Hong Kong short-term patent No. HK1228651; Granted on November 3, 2017.
Wong, W.K.R. (2017) Means and method for expression of authentic human epidermal growth factor and/or basic fibroblast growth factor in cytoplasm and/or culture medium of Escherichia coli Hong Kong short-term patent No. HK1219200; Granted on March 24, 2017.
Wong, W.K.R. (2017) Means and method for expression of authentic human epidermal growth factor and/or basic fibroblast growth factor in cytoplasm and/or culture medium of Escherichia coli US Patent No. 9,580,484 B2; Granted on February 28, 2017.
Wong, W.K.R., Ng, K. L. (2017) Means and method for enhancing growth of fish. Hong Kong short-term patent No.: HK1218486; Granted on February 17, 2017.
Wong, W.K.R. (2015)
Wong, W.K.R. (2015) Means and methods for producing authentic human basic fibroblast growth factor. US Patent: 9,017,968 B2; Granted on 28 April 2015.
Wong, W.K.R. (2014)
Wong, W.K.R., Lam, K.H.E. and Tsang, M.W. (2014) Method and composition for treating skin wounds with epidermal growth factor. German Patent 60346186.7; Granted on 18 Jun 2014.
Wong, W.K.R., Lam, K.H.E. and Tsang, M.W. (2014) Method and composition for treating skin wounds with epidermal growth factor. PCT European Patent EP1482966B1; Granted on 14 May 2014.
Wong, W.K.R., Lam, K.H.E. and Tsang, M.W. (2014) Method and composition for treating skin wounds with epidermal growth factor. United Kingdom Patent EP1482966; Granted on 14 May 2014.
Wong, W.K.R., Lam, K.H.E. and Tsang, M.W. (2014) Method and composition for treating skin wounds with epidermal growth factor. French Patent EP1482966; Granted on 14 May 2014.
Wong, W.K.R., Lam, K.H.E. and Tsang, M.W. (2014) Method and composition for treating skin wounds with epidermal growth factor. Hong Kong Patent HK1071525; Granted on 20 May 2014.
Wong, W.K.R. (2011)
Wong, W.K.R., Lam, K.H.E. and Tsang, M.W. (2011) Method and composition for treating skin wounds with epidermal growth factor. Taiwan PCT National Phase Patent, Taiwanese Patent No.: I 348912. Granted on 11 Sep 2011
Wong, W.K.R. (2009)
Wong, W.K.R., Lam, K.H.E. and Tsang, M.W. (2009) Method and composition for treating skin wounds with epidermal growth factor. China PCT National Phase Patent, Chinese Patent No. 3. Granted on 23 Dec 2009
Wong, W.K.R., Lam, K.H.E. and Tsang, M.W. (2009) Method and composition for treating skin wounds with epidermal growth factor. United States PCT National Phase Patent, US Patent No. 7,517,528 B2. Granted on 14 Apr 2009
獲獎榮譽
2020年度
Industry Advisor, “Certificate of Appointment” by Social Enterprise Research Academy
2018年度
Asian Chinese Leader, to be awarded by Asian College of Knowledge Management, 21 July 2018, Hong Kong
Fellowship, awarded by Social Enterprise Research Academy, 5 May 2018, Hong Kong
2017年度
Invited as a keynote speaker in the “International Conference on Genetics & Molecular Research”, May 22-24, 2017 at Dubai, UAE.
2016年度
Golden Medical Award, awarded by Global Medical Discovery. Canada
The Manager of the year and the Best Enterprises in the field of biotechnology, awarded by Europe Business Assembly
2015年度
“Certificate of Recognition” presented by the “International Conference on Targeting Diabetes and Novel Therapeutics” held on September 14-16 in Las Vegas, Nevada, USA
2014年度
Higher Education Outstanding Scientific Research Output Award, Nominated by HKUST
全球80位傑出華人企業家管理韬略與人文哲思，華商領軍者, awarded by 中國日報( China Daily) , 中國經濟出版社。
2013年度
香港傑出商社領袖人物, awarded by 文匯報 15 March 2013
2012年度
Named as one of the “中華愛國英才” and a 4-page introduction was published in <中華愛國國典> 2012
2011年度
Most Promising Entrepreneurship Award Winner of the prestigious Asia Pacific Entrepreneurship Awards, Hong Kong
Long Service Award, awarded by HKUST
2008年度
2008 Hong Kong Awards for Industries: Technological Achievement Certificate of Merit. Hong Kong Science & Technology Parks
榮譽證書
